Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-28 February 2019

March 1, 2019 – EMA’s human medicines committee (CHMP) recommended eight medicines for approval, including two orphan medicines1, at its February 2019 meeting. For three of the eight new medicines the CHMP recommended a conditional marketing authorisation. This was the last meeting of the CHMP in London. As of March 2019, all meetings will take place at the new EMA headquarters in Amsterdam. The Committee recommended granting a … (leggi tutto)